Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

March 26, 2019; 92 (13) Article

Socioeconomic status and disability progression in multiple sclerosis

A multinational study

View ORCID ProfileKatharine E. Harding, Mark Wardle, Robert Carruthers, Neil Robertson, Feng Zhu, Elaine Kingwell, Helen Tremlett
First published February 22, 2019, DOI: https://doi.org/10.1212/WNL.0000000000007190
Katharine E. Harding
From the Faculty of Medicine (Neurology) and Djavad Mowafaghian Centre for Brain Health (K.E.H., R.C., F.Z., E.K., H.T.), University of British Columbia, Vancouver, Canada; Institute of Psychological Medicine and Clinical Neuroscience (K.E.H., N.R.), Cardiff University, University Hospital of Cardiff; and Helen Durham Centre for Neuroinflammatory Disease, Department of Neurology (M.W., N.R.), University Hospital of Wales, Heath Park, Cardiff, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katharine E. Harding
Mark Wardle
From the Faculty of Medicine (Neurology) and Djavad Mowafaghian Centre for Brain Health (K.E.H., R.C., F.Z., E.K., H.T.), University of British Columbia, Vancouver, Canada; Institute of Psychological Medicine and Clinical Neuroscience (K.E.H., N.R.), Cardiff University, University Hospital of Cardiff; and Helen Durham Centre for Neuroinflammatory Disease, Department of Neurology (M.W., N.R.), University Hospital of Wales, Heath Park, Cardiff, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Carruthers
From the Faculty of Medicine (Neurology) and Djavad Mowafaghian Centre for Brain Health (K.E.H., R.C., F.Z., E.K., H.T.), University of British Columbia, Vancouver, Canada; Institute of Psychological Medicine and Clinical Neuroscience (K.E.H., N.R.), Cardiff University, University Hospital of Cardiff; and Helen Durham Centre for Neuroinflammatory Disease, Department of Neurology (M.W., N.R.), University Hospital of Wales, Heath Park, Cardiff, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil Robertson
From the Faculty of Medicine (Neurology) and Djavad Mowafaghian Centre for Brain Health (K.E.H., R.C., F.Z., E.K., H.T.), University of British Columbia, Vancouver, Canada; Institute of Psychological Medicine and Clinical Neuroscience (K.E.H., N.R.), Cardiff University, University Hospital of Cardiff; and Helen Durham Centre for Neuroinflammatory Disease, Department of Neurology (M.W., N.R.), University Hospital of Wales, Heath Park, Cardiff, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Feng Zhu
From the Faculty of Medicine (Neurology) and Djavad Mowafaghian Centre for Brain Health (K.E.H., R.C., F.Z., E.K., H.T.), University of British Columbia, Vancouver, Canada; Institute of Psychological Medicine and Clinical Neuroscience (K.E.H., N.R.), Cardiff University, University Hospital of Cardiff; and Helen Durham Centre for Neuroinflammatory Disease, Department of Neurology (M.W., N.R.), University Hospital of Wales, Heath Park, Cardiff, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elaine Kingwell
From the Faculty of Medicine (Neurology) and Djavad Mowafaghian Centre for Brain Health (K.E.H., R.C., F.Z., E.K., H.T.), University of British Columbia, Vancouver, Canada; Institute of Psychological Medicine and Clinical Neuroscience (K.E.H., N.R.), Cardiff University, University Hospital of Cardiff; and Helen Durham Centre for Neuroinflammatory Disease, Department of Neurology (M.W., N.R.), University Hospital of Wales, Heath Park, Cardiff, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen Tremlett
From the Faculty of Medicine (Neurology) and Djavad Mowafaghian Centre for Brain Health (K.E.H., R.C., F.Z., E.K., H.T.), University of British Columbia, Vancouver, Canada; Institute of Psychological Medicine and Clinical Neuroscience (K.E.H., N.R.), Cardiff University, University Hospital of Cardiff; and Helen Durham Centre for Neuroinflammatory Disease, Department of Neurology (M.W., N.R.), University Hospital of Wales, Heath Park, Cardiff, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Short Form
Citation
Socioeconomic status and disability progression in multiple sclerosis
A multinational study
Katharine E. Harding, Mark Wardle, Robert Carruthers, Neil Robertson, Feng Zhu, Elaine Kingwell, Helen Tremlett
Neurology Mar 2019, 92 (13) e1497-e1506; DOI: 10.1212/WNL.0000000000007190

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
252

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Abstract

Objective To examine the association between socioeconomic status (SES) and disability outcomes and progression in multiple sclerosis (MS).

Methods Health administrative and MS clinical data were linked for 2 cohorts of patients with MS in British Columbia (Canada) and South East Wales (UK). SES was measured at MS symptom onset (±3 years) based on neighborhood-level average income. The association between SES at MS onset and sustained and confirmed Expanded Disability Status Scale (EDSS) 6.0 and 4.0 and onset of secondary progression of MS (SPMS) were assessed using Cox proportional hazards models. EDSS scores were also examined via linear regression, using generalized estimating equations (GEE) with an exchangeable working correlation. Models were adjusted for onset age, sex, initial disease course, and disease-modifying drug exposure. Random effect models (meta-analysis) were used to combine results from the 2 cohorts.

Results A total of 3,113 patients with MS were included (2,069 from Canada; 1,044 from Wales). A higher SES was associated with a lower hazard of reaching EDSS 6.0 (adjusted hazard ratio [aHR] 0.90, 95% confidence interval [CI] 0.89–0.91), EDSS 4.0 (aHR 0.93, 0.88–0.98), and SPMS (aHR 0.94, 0.88–0.99). The direction of findings was similar when all EDSS scores were included (GEE: β = −0.13, −0.18 to −0.08).

Conclusions Lower neighborhood-level SES was associated with a higher risk of disability progression. Reasons for this association are likely to be complex but could include factors amenable to modification, such as lifestyle or comorbidity. Our findings are relevant for planning and development of MS services.

Glossary

BCMS=
British Columbia MS;
CI=
confidence interval;
DMT=
disease-modifying therapy;
EDSS=
Expanded Disability Status Scale;
GEE=
generalized estimating equations;
HR=
hazard ratio;
ICD=
International Classification of Diseases;
MS=
multiple sclerosis;
NHS=
National Health Service;
SES=
socioeconomic status;
SPMS=
secondary progressive multiple sclerosis

Footnotes

  • Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • Patient Page page e1536

  • Received September 7, 2018.
  • Accepted in final form November 16, 2018.
  • © 2019 American Academy of Neurology
View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Glossary
    • Methods
    • Results
    • Discussion
    • Author contributions
    • Study funding
    • Disclosure
    • Acknowledgment
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Related Articles

  • What is the impact of socioeconomic status on multiple sclerosis?About multiple sclerosis

Topics Discussed

  • Multiple sclerosis
  • Clinical trials Observational study (Cohort, Case control)
  • Natural history studies (prognosis)

Alert Me

  • Alert me when eletters are published
Neurology: 98 (19)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise